IL1B and Myocardial fibrosis: Researchers deleted cardiac fibroblasts’ IL-1 receptor and CCR2+ monocytes and macrophages’ IL-1β ligand and inhibited IL-1β signaling by a specific antibody, and results showed that myocardial fibrosis and cardiac function were well improved.